4.0 Review

Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany

Related references

Note: Only part of the references are listed.
Article Rheumatology

Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents

A. M. Kerola et al.

Summary: The prevalence and use of biologic agents in psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), and rheumatoid arthritis (RA) in Norway were estimated. The combined prevalence of these diseases was over 1.5%, and more than 25% of patients used biologic agents, accounting for 0.4% of the Norwegian adult population.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Article Public, Environmental & Occupational Health

Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross-sectional patient-reported survey data

Johanna Callhoff et al.

Summary: This study evaluated different algorithms for identifying rheumatoid arthritis (RA) in claims data, and found that the ICD-10 codes and prescription of specific medication were effective in identifying RA patients.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023)

Article Rheumatology

Incidence and prevalence of juvenile idiopathic arthritis in the United Kingdom, 2000-2018: results from the Clinical Practice Research Datalink

Ruth Costello et al.

Summary: This study provides updated national estimates of the incidence and prevalence of JIA in the UK. It finds that there has been no significant change in the rates over the past 25 years and that Scotland has higher rates compared to England.

RHEUMATOLOGY (2022)

Article Rheumatology

Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study

Helga Westerlind et al.

Summary: The study presents an in-depth report on the incidence and prevalence of systemic sclerosis (SSc) in Sweden. The findings suggest that SSc incidence and prevalence in Sweden are comparable to estimates from southern Europe, contrary to previous assumptions of lower occurrence in northern Europe. The study also reveals that SSc incidence has remained stable in Sweden in recent years without a significant increase. Women have a higher incidence and prevalence of SSc compared to men.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

Article Rheumatology

Is the prevalence of rheumatoid arthritis truly on the rise?

Katinka Albrecht et al.

Summary: An increasing number of health insurance data analyses in Germany show a rise in the prevalence of rheumatoid arthritis (RA), with different studies varying in their case definitions and the frequency of the diagnosis.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2022)

Review Medicine, General & Internal

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Rocio Redondo-Rodriguez et al.

Summary: This study aimed to evaluate the worldwide incidence and prevalence of ANCA-associated vasculitis (AAV), with results showing an increasing trend over time, especially in the case of GPA. AAV was found to be more predominant in the northern hemisphere, with higher incidence in America and pooled prevalence in America and Europe.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, General & Internal

Polymyalgia Rheumatica Sex-Specific Epidemiology, Diagnostic and Therapeutic Approach, and Medical Care

Miriam Giovanna Colombo et al.

Summary: Polymyalgia rheumatica (PMR) is one of the most common inflammatory rheumatic diseases in older adults, with presumed risk factors including female sex, previous infections, and genetic factors. There has been a lack of epidemiological data on PMR in Germany until now, prompting this study. The results showed that the annual incidence and prevalence of PMR from 2011 to 2019 were 18.6/100,000 persons and 138.8/100,000 persons, respectively, with higher incidence in women than men. 60% of cases were diagnosed in primary care practices. The importance of non-pharmacological treatment for older patients with PMR who have impaired physical ability was emphasized.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2022)

Article Respiratory System

Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study

Malene Knarborg et al.

Summary: This nationwide population-based study investigated the incidence and prevalence of Systemic Sclerosis (SSc) and its association with interstitial lung disease (SSc-ILD). The study found that male sex and age between 41 and 50 years were associated with ILD in SSc patients.

CHRONIC RESPIRATORY DISEASE (2022)

Article Dermatology

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis

Maximilian Reinhardt et al.

Summary: Psoriatic arthritis is a common manifestation of psoriasis and has a significant impact on physical functioning, work ability and quality of life. A German study found that 2.6% of adult patients with psoriasis developed concomitant psoriatic arthritis within five years. Cardiovascular diseases are the most frequent comorbidity, while depression and neurosis/stress disorder were identified as indicators for the development of psoriatic arthritis.

ACTA DERMATO-VENEREOLOGICA (2021)

Article Rheumatology

New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study

Bernhard Hellmich et al.

Summary: This study used claims data analysis to assess the epidemiology of AAV in Germany, finding that the prevalence of AAV patients may be higher than previously estimated by registry-based studies. This suggests that epidemiological data of AAV may have been underestimated but may also reflect improved diagnostic methods and disease recognition.

RHEUMATOLOGY (2021)

Article Rheumatology

The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization

Andreas Schwarting et al.

Summary: The study found that the incidence of SLE in Germany increased by 1.4 times over 5 years. Patients with SLE have higher healthcare costs, and costs increase with baseline severity. Early and effective treatments may delay disease progression and reduce the burden of SLE.

RHEUMATOLOGY AND THERAPY (2021)

Article Rheumatology

Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany

Madeline Deike et al.

Summary: The study provides a comprehensive analysis of age-dependent risk of PsA, focusing on varying incidences within different age groups. Results show that the incidence of PsA increases with age until a peak slightly before age 60, then declines. Incidence is higher in women than in men, and shows an increasing trend over the survey period.

RMD OPEN (2021)

Article Rheumatology

Prescription of analgesics in patients with rheumatic diseases in Germany A claims data analysis

K. Albrecht et al.

Summary: In Germany in 2019, the prescription frequency of analgesics for inflammatory rheumatic diagnoses is relatively low, with nonsteroidal anti-inflammatory drugs/coxibs (35%-50%) and metamizole (29%-33%) being the most commonly prescribed; the proportion of opioid prescriptions remained stable from 2005 to 2019, but the proportion of long-term use showed an increasing trend.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2021)

Article Medicine, General & Internal

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The article introduces PRISMA 2020, an updated reporting guideline for systematic reviews and meta-analyses.

PLOS MEDICINE (2021)

Article Environmental Sciences

Age and Sex Specific Trends in Incidence of Juvenile Idiopathic Arthritis in Danish Birth Cohorts from 1992 to 2002: A Nationwide Register Linkage Study

Isabel Cardoso et al.

Summary: This study found that the incidence rates of JIA in Denmark remained stable from 1992 to 2002, with higher rates in girls than in boys, and two peaks in girls at ages 0-5 years and 12-15 years.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Medicine, Research & Experimental

Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study

Claudia Grellmann et al.

Summary: The prevalence rates of RA, PsA, and PSO in Germany remained consistent from 2012 to 2016, with RA and PsA being more prevalent in women and PSO having an equal gender distribution. Depressive episodes were the most common comorbidity reported, and methotrexate was the most commonly used systemic treatment, while biologic therapies were less frequently used.

ADVANCES IN THERAPY (2021)

Article Public, Environmental & Occupational Health

Prevalence of Rheumatoid Arthritis in Germany: Analysis of Longitudinal Data of Statutory Health Insurance

Carsten Kienitz et al.

Summary: The study analyzed anonymized diagnosis and prescription data for approximately 2.3 million insured adults in Germany and found that the prevalence of rheumatoid arthritis (RA) was around 1.26%. More than 90% of the diagnoses were based on the code M06, and only about 40% of diagnosed patients were treated with disease-modifying antirheumatic drugs (DMARDs).

GESUNDHEITSWESEN (2021)

Article Dermatology

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis

Maximilian Reinhardt et al.

Summary: Psoriatic arthritis, a common manifestation of psoriasis, significantly impacts patients' quality of life. Little research has been done on its epidemiology and risk factors, but findings suggest cardiovascular diseases, depression, and neurosis/stress disorder are associated with the development of psoriatic arthritis.

ACTA DERMATO-VENEREOLOGICA (2021)

Article Public, Environmental & Occupational Health

Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC)

Carsten Oliver Schmidt et al.

BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2020)

Review Rheumatology

Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review

Ankita Sharma et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)

Letter Rheumatology

Prevalence and incidence of psoriasis and psoriatic arthritis

Philipp Sewerin et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Article Rheumatology

Contemporary epidemiology of systemic sclerosis: A population-based cohort study in the United Kingdom

Luis A. Garcia Rodriguez et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)

Article Dermatology

Analysis of pharmaceutical care in patients with psoriatic arthritis using statutory health insurance data

Wiebke Sondermann et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2018)

Review Rheumatology

Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis

Lorenza Scotti et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)

Editorial Material Rheumatology

How frequent are musculoskeletal diseases in Germany?

A. Zink et al.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2016)

Article Rheumatology

The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012

Frances Rees et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Review Rheumatology

Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis

Baodong Qin et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Article Health Care Sciences & Services

Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement

Damian Hoy et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)

Article Rheumatology

Epidemiology of primary Sjorgren's syndrome

G. Westhoff et al.

ZEITSCHRIFT FUR RHEUMATOLOGIE (2010)

Article Dermatology

Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey

M. A. Radtke et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)